Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery

被引:16
|
作者
Bajorath, Juergen [1 ]
机构
[1] Rhein Freidrich Wilhelms Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, D-53113 Bonn, Germany
关键词
chemical biology; chemogenomics; computational methods; drug-target networks; ligand selectivity; ligand-target interactions; pharmacological space; polypharmacology; small molecules; target families;
D O I
10.1517/17460440802536496
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Chemical biology and chemogenomics are rapidly evolving disciplines at interfaces between chemistry and the life sciences and are highly interdisciplinary in nature. Chemogenomics has a strong conceptional link to modern drug discovery research, whereas chemical biology focuses more on the use of small molecules as probes for exploring biological functions, rather than drug candidates. However, the boundaries between these areas are fluid, as they should be, given their strong interdisciplinary orientation. Objective: Recently, computational approaches have been introduced for the analysis of research topics that are of considerable relevance for these disciplines including, for example, the systematic study of ligand-target interactions or mapping of pharmacologically relevant chemical space. This contribution introduces key investigations in computational chemical biology and chemogenomics and critically evaluates their current and future potential to impact drug discovery. Conclusions: Computational methods of high relevance for chemogenomics and chemical biology either derive knowledge from large-scale analysis of available drug and target data or interface experimental programs with predictive methods. Approaches for drug target prediction and the systematic analysis of polypharmacology substantially impact research in this area.
引用
收藏
页码:1371 / 1376
页数:6
相关论文
共 50 条
  • [31] Drug discovery inspired by chemical biology
    Osada, Hiroyuki
    Imoto, Masaya
    CANCER SCIENCE, 2018, 109 : 149 - 149
  • [32] Structural transitional chemogenomics and structural transitional chemoproteomics: two novel drug discovery approaches
    Gagna, CE
    Chan, N
    Lambert, WC
    FASEB JOURNAL, 2005, 19 (04): : A852 - A852
  • [33] Structural biology approaches to antibacterial drug discovery
    Holler, Tod P.
    Evdokimov, Artem G.
    Narasimhan, Lakshmi
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (08) : 1085 - 1101
  • [34] The impact of molecular biology on drug discovery
    Belfield, GP
    Delaney, SJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 : 313 - 316
  • [35] The impact of synthetic biology on drug discovery
    Weber, Wilfried
    Fussenegger, Martin
    DRUG DISCOVERY TODAY, 2009, 14 (19-20) : 956 - 963
  • [36] Computational neuropharmacology:: dynamical approaches in drug discovery
    Aradi, Ildiko
    rdi, Péter
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (05) : 240 - 243
  • [37] Computational approaches in target identification and drug discovery
    Katsila, Theodora
    Spyroulias, Georgios A.
    Patrinos, George P.
    Matsoukas, Minos-Timotheos
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2016, 14 : 177 - 184
  • [38] Computational and In Vitro ADME Approaches in Drug Discovery
    Waters, Nigel
    JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (07) : 891 - 891
  • [40] Computational approaches for innovative antiepileptic drug discovery
    Talevi, Alan
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (10) : 1001 - 1016